If IL-6 is the major factor contributing to this enhanced growth, then the much higher production of IL-6 by MDA-MB-231 breast cancer cells versus MDA-MB-468 breast cancer cells (Figure 2C) would account for the lack in enhanced cell proliferation effect in MDA-MB-468 breast cancer cells. The gene discussed is IL6; the disease is breast cancer.